Literature DB >> 9496904

Identification of intermediate cell types by keratin expression in the developing human prostate.

Y Xue1, F Smedts, F M Debruyne, J J de la Rosette, J A Schalken.   

Abstract

BACKGROUND: The secretory acini of the adult human prostate contain basal, luminal, and intermediate types of exocrine cells. Intermediate cells are thought to play an important role in normal growth and neoplastic transformation. In this study we investigated whether this cell type is present in early stages of prostate development, using keratin antibodies specific for them.
METHODS: Autoptic tissue from 11 prepubertal and 5 normal adult prostates was immunohistochemically stained with four keratin antibodies capable of specifically detecting basal, luminal, or intermediate cell types.
RESULTS: Morphologically, in fetal prostate cells differentiation was often not evident. However, basally located cells usually displayed a basal-cell keratin-phenotype. Morphologically similar cells with more luminal localization expressed keratins typical of luminal cells, or of intermediate cells.
CONCLUSIONS: 1) In early stages of prostate development, cells with intermediate keratin-phenotype can be identified. 2) Their large numbers comply with a hierarchical pathway of cellular differentiation from basal to luminal cells. 3) The presence of intermediate cells at such an early fetal age may reflect their regulatory function in prostate development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496904     DOI: 10.1002/(sici)1097-0045(19980301)34:4<292::aid-pros7>3.0.co;2-j

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  34 in total

1.  Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland.

Authors:  L Jiang; F Ivich; S Tahsin; M Tran; S B Frank; C K Miranti; Y Zohar
Journal:  Biomicrofluidics       Date:  2019-11-20       Impact factor: 2.800

Review 2.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Prostate epithelial stem cell culture.

Authors:  David L Hudson
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation.

Authors:  M Fornaro; M Manzotti; G Tallini; A E Slear; S Bosari; E Ruoslahti; L R Languino
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines.

Authors:  Matthew P Dent; Samantha J Madnick; Susan Hall; Marguerite Vantangoli Policelli; Chloe Bars; Hui Li; Ali Amin; Paul L Carmichael; Francis L Martin; Kim Boekelheide
Journal:  Toxicol In Vitro       Date:  2019-05-30       Impact factor: 3.500

Review 6.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

Review 7.  Prostate cancer stem cells.

Authors:  Shi-Ming Tu; Sue-Hwa Lin
Journal:  Clin Genitourin Cancer       Date:  2012-03-14       Impact factor: 2.872

8.  Multipotent and unipotent progenitors contribute to prostate postnatal development.

Authors:  Marielle Ousset; Alexandra Van Keymeulen; Gaëlle Bouvencourt; Neha Sharma; Younes Achouri; Benjamin D Simons; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2012-10-14       Impact factor: 28.824

9.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

Authors:  A M De Marzo; A K Meeker; J I Epstein; D S Coffey
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

10.  Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.

Authors:  G A Gmyrek; M Walburg; C P Webb; H M Yu; X You; E D Vaughan; G F Vande Woude; B S Knudsen
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.